Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects

Clinical trial NCT00845429 · COMPLETED

Trial details

NCT number: NCT00845429
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza Orthomyxoviruses Myxovirus Infection

Start date: 2007-10-01
Primary completion: 2008-08-01
Enrollment: 729

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.